The resolution phase of the inflammatory process is closely connected to immune homeostasis—the ability of the immune system to appropriately activate in response to a challenge, modulate that response, and return toward a balanced state once the challenge has been addressed. Building on emerging research into inflammatory resolution, specialized pro-resolving mediators (SPMs) are increasingly being studied for their broader effects on immune-cell function and communication.
A recent review published in Autoimmunity Reviews examined the relationship between SPM biology and autoimmunity. The review describes SPMs as regulators of both innate and adaptive immune responses, with evidence that alterations in SPM biosynthesis, receptor expression, or signaling may contribute to persistent inflammation and autoimmune pathology.
SPMs appear to influence multiple immune-cell populations, including neutrophils, macrophages, dendritic cells, and lymphocytes. Their effects include regulating leukocyte recruitment, promoting inflammation-resolving macrophage activity, facilitating the clearance of cellular debris, and modulating adaptive immune responses. Collectively, these actions suggest that SPMs may help coordinate immune activity across different stages of the inflammatory response.
This broader regulatory role is particularly relevant when immune activation persists beyond the initial stimulus. In rheumatoid arthritis (RA) and other autoimmune conditions, ongoing immune activation can contribute to sustained cytokine signaling, leukocyte recruitment, and tissue injury. The evidence reviewed in Autoimmunity Reviews suggests that altered SPM pathways may be one factor associated with this persistent inflammatory environment. The authors identify SPM biology as an emerging area of therapeutic investigation while emphasizing the need for further research to clarify mechanisms and clinical applications.
A 2022 review published in Biomedicine & Pharmacotherapy similarly examined the effects of SPMs across innate and adaptive immune populations. The review described effects on neutrophil migration, macrophage activity, dendritic-cell function, and lymphocyte responses, supporting the concept that SPMs can influence coordinated immune-cell behavior rather than acting on a single inflammatory pathway.
Emerging experimental research provides additional insight into how pro-resolving signaling may influence the timing of immune responses. A 2024 study published in Molecular Medicine investigated repeated low-dose administration of a panel of SPMs following microbial inflammation in mice. The researchers observed accelerated clearance of inflammatory neutrophils and a reduction of more than 70% in the resolution interval, along with changes in genes and pathways associated with immune responses, chemokine clearance, and tissue repair.
These findings provide further evidence that resolution is an actively regulated biological process and that pro-resolving signaling can influence the coordination and timing of appropriate immune responses. Importantly, the study was conducted in an experimental animal model using administered SPMs; therefore, the findings should not be interpreted as evidence of equivalent effects from SPM supplementation in humans.
Together, these findings broaden the role of SPMs from mediators involved in resolving inflammation to potential regulators of immune-cell behavior and immune homeostasis. By influencing both innate and adaptive immune responses, SPMs may support the immune system’s transition from activation toward resolution while promoting the cellular processes required for recovery.
Maintaining immune homeostasis is ultimately an integrative, holistic process. Adequate nutrition, restorative sleep and movement, circadian rhythm, nature, yoga and meditation, and healthy stress adaptation all contribute to the physiological conditions that support appropriate immune responses and recovery. Within this broader context, SPMs represent one component of the body's valuable endogenous mechanisms for modulating immune activity and supporting the return toward homeostasis.